Changes in Beta-Cell Function during Dapagliflozin Therapy in Combination with Exenatide in Type 2 Diabetes Patients (T2D)

被引：0
|
作者：
Defronzo, Ralph A.
Baskoy, Gozde
Triplitt, Curtis L.
Cersosimo, Eugenio
Solis-Herrera, Carolina
Adams, John M., II
Hansis-Diarte, Andrea A.
Gastaldelli, Amalia
Chavez, Alberto
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1550-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1550-P
引用
收藏
页数：3
相关论文
共 50 条
  • [21] GEOGRAPHIC VARIATIONS IN KIDNEY FUNCTION TESTING AMONG PATIENTS WITH TYPE 2 DIABETES (T2D)
    Feng, Xue
    Betts, Keith A.
    Song, Jinlin
    Wu, Aozhou
    Elliott, Jay
    Warnock, Neil
    Farej, Ryan
    Singh, Rakesh
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 77 (04) : 592 - 593
  • [22] Beta-Cell Function and Type 2 Diabetes in Africans and Asian Indians
    Staimez, Lisa R.
    Shah, Rohan
    Deepa, Mohan
    Matsha, Tandi E.
    Anjana, Ranjit Mohan
    Erasmus, Rajiv T.
    Mohan, Viswanathan
    Mabundo, Lilian
    Dubose, Christopher
    Narayan, K. M. Venkat
    Dagogo-Jack, Samuel
    Kengne, Andre Pascal
    Sumner, Anne E.
    DIABETES, 2022, 71
  • [23] Beta-Cell Dedifferentiation and Type 2 Diabetes
    Dor, Yuval
    Glaser, Benjamin
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (06): : 572 - 573
  • [24] Beta-cell loss in type 2 diabetes
    Kahn, S. E.
    DIABETES OBESITY & METABOLISM, 2010, 12 : 12 - 12
  • [25] Combination therapy with saxagliptin and dapagliflozin for the treatment of type 2 diabetes
    Williams, David M.
    Stephens, Jeffrey W.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (15) : 2373 - 2379
  • [26] Combination therapy for type 2 diabetes: dapagliflozin plus metformin
    Tan, Xueying
    Hu, Jingbo
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (01) : 117 - 126
  • [27] Type 2 Diabetes (T2D) Susceptibility Loci and Beta Cell Defects in Islets (ISLs) from Non-Diabetic (ND) and T2D Subjects
    Del Guerra, Silvia
    Groves, Christopher
    D'Aleo, Valentina
    Lupi, Roberto
    Maccarthy, Mark
    Marchetti, Piero
    DIABETES, 2011, 60 : A387 - A387
  • [28] Exenatide and Dapagliflozin to reduce Liver Fat in Patients with Type-2-Diabetes
    Kahl, S.
    DIABETOLOGE, 2021, 17 (03): : 344 - 346
  • [29] Type 2 Diabetes (T2D) in Adolescents Living in a Low-Middle Income Country (LMIC)-Peru: Insulin Resistance or Beta-Cell Dysfunction?
    Zelada, Henry J.
    Miranda Hurtado, Cesar J.
    Condezo Aliaga, Diana I.
    Aro Guardia, Pedro A.
    Carnero, Andres M.
    Loza Munarriz, Cesar A.
    Manrique Hurtado, Helard A.
    DIABETES, 2015, 64 : A669 - A669
  • [30] GAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study
    Hampe, Christiane S.
    Shojaie, Ali
    Brooks-Worrell, Barbara
    Dibay, Sepideh
    Utzschneider, Kristina
    Kahn, Steven E.
    Larkin, Mary E.
    Johnson, Mary L.
    Younes, Naji
    Rasouli, Neda
    Desouza, Cyrus
    Cohen, Robert M.
    Park, Jean Y.
    Florez, Hermes J.
    Valencia, Willy Marcos
    Stempel, Robert
    Palmer, Jerry P.
    Balasubramanyam, Ashok
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (03)
12345